These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35946932)

  • 1. The win odds: statistical inference and regression.
    Song J; Verbeeck J; Huang B; Hoaglin DC; Gamalo-Siebers M; Seifu Y; Wang D; Cooner F; Dong G
    J Biopharm Stat; 2023 Mar; 33(2):140-150. PubMed ID: 35946932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of inferential methods for the net benefit and win ratio statistics.
    Verbeeck J; Ozenne B; Anderson WN
    J Biopharm Stat; 2020 Sep; 30(5):765-782. PubMed ID: 32097079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of the win odds in the design of non-inferiority clinical trials.
    Peng L
    J Biopharm Stat; 2020 Sep; 30(5):941-946. PubMed ID: 32475213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stratified win statistics (win ratio, win odds, and net benefit).
    Dong G; Hoaglin DC; Huang B; Cui Y; Wang D; Cheng Y; Gamalo-Siebers M
    Pharm Stat; 2023; 22(4):748-756. PubMed ID: 36808217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjusting win statistics for dependent censoring.
    Dong G; Huang B; Wang D; Verbeeck J; Wang J; Hoaglin DC
    Pharm Stat; 2021 May; 20(3):440-450. PubMed ID: 33247544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Win statistics (win ratio, win odds, and net benefit) can complement one another to show the strength of the treatment effect on time-to-event outcomes.
    Dong G; Huang B; Verbeeck J; Cui Y; Song J; Gamalo-Siebers M; Wang D; Hoaglin DC; Seifu Y; Mütze T; Kolassa J
    Pharm Stat; 2023 Jan; 22(1):20-33. PubMed ID: 35757986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stratified win ratio.
    Dong G; Qiu J; Wang D; Vandemeulebroecke M
    J Biopharm Stat; 2018; 28(4):778-796. PubMed ID: 29172988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust statistical inference for matched win statistics.
    Matsouaka RA
    Stat Methods Med Res; 2022 Aug; 31(8):1423-1438. PubMed ID: 35578578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A class of proportional win-fractions regression models for composite outcomes.
    Mao L; Wang T
    Biometrics; 2021 Dec; 77(4):1265-1275. PubMed ID: 32974905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large sample inference for a win ratio analysis of a composite outcome based on prioritized components.
    Bebu I; Lachin JM
    Biostatistics; 2016 Jan; 17(1):178-87. PubMed ID: 26353896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence synthesis analysis with prioritized benefit outcomes in oncology clinical trials.
    Cui Y; Dong G; Kuan PF; Huang B
    J Biopharm Stat; 2023 May; 33(3):272-288. PubMed ID: 36343174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stratified proportional win-fractions regression analysis.
    Wang T; Mao L
    Stat Med; 2022 Nov; 41(26):5305-5318. PubMed ID: 36104953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A generalized analytic solution to the win ratio to analyze a composite endpoint considering the clinical importance order among components.
    Dong G; Li D; Ballerstedt S; Vandemeulebroecke M
    Pharm Stat; 2016 Sep; 15(5):430-7. PubMed ID: 27485522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Win Statistics in Observational Cancer Research: Integrating Clinical and Quality-of-Life Outcomes.
    Chiaruttini MV; Lorenzoni G; Spolverato G; Gregori D
    J Clin Med; 2024 May; 13(11):. PubMed ID: 38892983
    [No Abstract]   [Full Text] [Related]  

  • 16. Covariate-adjusted generalized pairwise comparisons in small samples.
    Jaspers S; Verbeeck J; Thas O
    Stat Med; 2024 Sep; 43(21):4027-4042. PubMed ID: 38963080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Win odds: An adaptation of the win ratio to include ties.
    Brunner E; Vandemeulebroecke M; Mütze T
    Stat Med; 2021 Jun; 40(14):3367-3384. PubMed ID: 33860957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fallacies of Using the Win Ratio in Cardiovascular Trials: Challenges and Solutions.
    Ajufo E; Nayak A; Mehra MR
    JACC Basic Transl Sci; 2023 Jun; 8(6):720-727. PubMed ID: 37426527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of win time for ordered composite endpoints in clinical trials.
    Troendle JF; Leifer ES; Yang S; Jeffries N; Kim DY; Joo J; O'Connor CM
    Stat Med; 2024 May; 43(10):1920-1932. PubMed ID: 38417455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A win ratio approach to comparing continuous non-normal outcomes in clinical trials.
    Wang D; Pocock S
    Pharm Stat; 2016 May; 15(3):238-45. PubMed ID: 26970432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.